Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Dec;65(6):810–821. doi: 10.1136/jnnp.65.6.810

Neurology and the kidney

D Burn 1, D Bates 1
PMCID: PMC2170399  PMID: 9854955

Abstract

Renal failure is relatively common, but except in association with spina bifida or paraplegia it is unlikely to occur as a result of disease of the CNS. Renal failure, however, commonly affects the nervous system. The effects of kidney failure on the nervous system are more pronounced when failure is acute. In addition to the important problems related to renal failure there are both acquired and genetically determined diseases which may affect the kidney and the brain. Those acquired diseases include the vasculitides, the paraproteinaemias, and various granulomatous conditions (considered in other chapters of Neurology and Medicine). In two of the most commonly encountered genetically determined diseases, Von Hippel-Lindau disease and polycystic kidney disease, location of pathogenic mutations will provide improved screening programmes and, possibly, allow therapeutic intervention. Uraemia may affect both the central and peripheral nervous systems. Whereas the clinical features of uraemia are well documented, the pathophysiology is less well understood and probably multifactorial. Uraemic encephalopathy, which classically fluctuates, is associated with problems in cognition and memory and may progress to delirium, convulsions, and coma. The encephalopathy may initially worsen with periods of dialysis and almost certainly relates to altered metabolic states in association with ionic changes and possibly impaired synaptic function. Renal failure may affect the peripheral nervous system, resulting in a neuropathy which shows a predilection for large diameter axons. This may be reversed by dialysis and transplantation. The myopathy seen in renal failure, often associated with bone pain and tenderness, is similar to that encountered in primary hyperparathyroidism and osteomalacia.
 Dialysis itself is associated with neurological syndromes including the dysequilibrium syndrome, subdural haematoma, and Wernicke's encephalopathy. Dialysis dementia, which was prevalent during the 1970s, has reduced in frequency with the use of aluminium free dialysate. With the introduction of transplantation and the concomitant use of powerful immunosuppressive drugs, the pattern of neurological problems encountered in renal replacement therapy has shifted. Five per cent of patients develop nerve injuries during renal transplantation, and up to 40% of patients experience neurological side effects from cyclosporine. Furthermore, CNS infections, often fungal in type, have been reported in up to 45% of transplant patients coming to postmortem. The nature of the involvement of neurologists with their nephrology colleagues is therefore evolving.



Full Text

The Full Text of this article is available as a PDF (175.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alfrey A. C., LeGendre G. R., Kaehny W. D. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med. 1976 Jan 22;294(4):184–188. doi: 10.1056/NEJM197601222940402. [DOI] [PubMed] [Google Scholar]
  2. Alfrey A. C., Mishell J. M., Burks J., Contiguglia S. R., Rudolph H., Lewin E., Holmes J. H. Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs. 1972;18(0):257-61, 266-7. doi: 10.1097/00002480-197201000-00064. [DOI] [PubMed] [Google Scholar]
  3. Arieff A. I., Guisado R., Massry S. G., Lazarowitz V. C. Central nervous system pH in uremia and the effects of hemodialysis. J Clin Invest. 1976 Aug;58(2):306–311. doi: 10.1172/JCI108473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Balmaceda C., Gaynor J. J., Sun M., Gluck J. T., DeAngelis L. M. Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications. Ann Neurol. 1995 Aug;38(2):202–209. doi: 10.1002/ana.410380212. [DOI] [PubMed] [Google Scholar]
  5. Bruno A., Adams H. P., Jr Neurologic problems in renal transplant recipients. Neurol Clin. 1988 May;6(2):305–325. [PubMed] [Google Scholar]
  6. Candy J. M., McArthur F. K., Oakley A. E., Taylor G. A., Chen C. P., Mountfort S. A., Thompson J. E., Chalker P. R., Bishop H. E., Beyreuther K. Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure. J Neurol Sci. 1992 Feb;107(2):210–218. doi: 10.1016/0022-510x(92)90291-r. [DOI] [PubMed] [Google Scholar]
  7. Chokroverty S., Bruetman M. E., Berger V., Reyes M. G. Progressive dialytic encephalopathy. J Neurol Neurosurg Psychiatry. 1976 May;39(5):411–419. doi: 10.1136/jnnp.39.5.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Choyke P. L., Glenn G. M., Walther M. M., Patronas N. J., Linehan W. M., Zbar B. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology. 1995 Mar;194(3):629–642. doi: 10.1148/radiology.194.3.7862955. [DOI] [PubMed] [Google Scholar]
  9. Cogan M. G., Covey C. M., Arieff A. I., Wisniewski A., Clark O. H., Lazarowitz V., Leach W. Central nervous system manifestations of hyperparathyroidism. Am J Med. 1978 Dec;65(6):963–970. doi: 10.1016/0002-9343(78)90748-9. [DOI] [PubMed] [Google Scholar]
  10. Fehlings M. G., Gentili F. The association between polycystic kidney disease and cerebral aneurysms. Can J Neurol Sci. 1991 Nov;18(4):505–509. doi: 10.1017/s0317167100032248. [DOI] [PubMed] [Google Scholar]
  11. Filling-Katz M. R., Choyke P. L., Oldfield E., Charnas L., Patronas N. J., Glenn G. M., Gorin M. B., Morgan J. K., Linehan W. M., Seizinger B. R. Central nervous system involvement in Von Hippel-Lindau disease. Neurology. 1991 Jan;41(1):41–46. doi: 10.1212/wnl.41.1.41. [DOI] [PubMed] [Google Scholar]
  12. Fraser C. L., Arieff A. I. Nervous system complications in uremia. Ann Intern Med. 1988 Jul 15;109(2):143–153. doi: 10.7326/0003-4819-109-2-143. [DOI] [PubMed] [Google Scholar]
  13. Guay-Woodford L. M., Muecher G., Hopkins S. D., Avner E. D., Germino G. G., Guillot A. P., Herrin J., Holleman R., Irons D. A., Primack W. The severe perinatal form of autosomal recessive polycystic kidney disease maps to chromosome 6p21.1-p12: implications for genetic counseling. Am J Hum Genet. 1995 May;56(5):1101–1107. [PMC free article] [PubMed] [Google Scholar]
  14. Guisado R., Arieff A. I., Massry S. G., Lazarowitz V., Kerian A. Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes. J Clin Invest. 1975 Apr;55(4):738–745. doi: 10.1172/JCI107984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hinchey J., Chaves C., Appignani B., Breen J., Pao L., Wang A., Pessin M. S., Lamy C., Mas J. L., Caplan L. R. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 Feb 22;334(8):494–500. doi: 10.1056/NEJM199602223340803. [DOI] [PubMed] [Google Scholar]
  16. Hossack K. F., Leddy C. L., Johnson A. M., Schrier R. W., Gabow P. A. Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med. 1988 Oct 6;319(14):907–912. doi: 10.1056/NEJM198810063191404. [DOI] [PubMed] [Google Scholar]
  17. Hughes J. R., Schreeder M. T. EEG in dialysis encephalopathy. Neurology. 1980 Nov;30(11):1148–1154. doi: 10.1212/wnl.30.11.1148. [DOI] [PubMed] [Google Scholar]
  18. Jack R., Rabin P. L., McKinney T. D. Dialysis encephalopathy: a review. Int J Psychiatry Med. 1983;13(4):309–326. doi: 10.2190/c36r-6wgp-lcyu-9vrg. [DOI] [PubMed] [Google Scholar]
  19. Jagadha V., Deck J. H., Halliday W. C., Smyth H. S. Wernicke's encephalopathy in patients on peritoneal dialysis or hemodialysis. Ann Neurol. 1987 Jan;21(1):78–84. doi: 10.1002/ana.410210114. [DOI] [PubMed] [Google Scholar]
  20. Kerr D. N., Ward M. K., Ellis H. A., Simpson W., Parkinson I. S. Aluminium intoxication in renal disease. Ciba Found Symp. 1992;169:123–141. doi: 10.1002/9780470514306.ch8. [DOI] [PubMed] [Google Scholar]
  21. Latif F., Tory K., Gnarra J., Yao M., Duh F. M., Orcutt M. L., Stackhouse T., Kuzmin I., Modi W., Geil L. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993 May 28;260(5112):1317–1320. doi: 10.1126/science.8493574. [DOI] [PubMed] [Google Scholar]
  22. Leonard A., Shapiro F. L. Subdural hematoma in regularly hemodialyzed patients. Ann Intern Med. 1975 May;82(5):650–658. doi: 10.7326/0003-4819-82-5-650. [DOI] [PubMed] [Google Scholar]
  23. Lockwood A. H. Neurologic complications of renal disease. Neurol Clin. 1989 Aug;7(3):617–627. [PubMed] [Google Scholar]
  24. Lozano A. M., Leblanc R. Cerebral aneurysms and polycystic kidney disease: a critical review. Can J Neurol Sci. 1992 May;19(2):222–227. [PubMed] [Google Scholar]
  25. Maher E. R., Yates J. R., Harries R., Benjamin C., Harris R., Moore A. T., Ferguson-Smith M. A. Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990 Nov;77(283):1151–1163. doi: 10.1093/qjmed/77.2.1151. [DOI] [PubMed] [Google Scholar]
  26. Moore P. M., Richardson B. Neurology of the vasculitides and connective tissue diseases. J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):10–22. doi: 10.1136/jnnp.65.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Neumann H. P., Eggert H. R., Weigel K., Friedburg H., Wiestler O. D., Schollmeyer P. Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg. 1989 Jan;70(1):24–30. doi: 10.3171/jns.1989.70.1.0024. [DOI] [PubMed] [Google Scholar]
  28. Okada J., Yoshikawa K., Matsuo H., Kanno K., Oouchi M. Reversible MRI and CT findings in uremic encephalopathy. Neuroradiology. 1991;33(6):524–526. doi: 10.1007/BF00588046. [DOI] [PubMed] [Google Scholar]
  29. Ong A. C. Renal disease. II. The polycystic kidney disease 1 (PKD-1) gene: an important clue in the study of renal cyst formation. J R Coll Physicians Lond. 1997 Mar-Apr;31(2):141–146. [PMC free article] [PubMed] [Google Scholar]
  30. Patchell R. A. Neurological complications of organ transplantation. Ann Neurol. 1994 Nov;36(5):688–703. doi: 10.1002/ana.410360503. [DOI] [PubMed] [Google Scholar]
  31. Pollard J. D., Young G. A. Neurology and the bone marrow. J Neurol Neurosurg Psychiatry. 1997 Dec;63(6):706–718. doi: 10.1136/jnnp.63.6.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pracyk J. B., Massey J. M. Moyamoya disease associated with polycystic kidney disease and eosinophilic granuloma. Stroke. 1989 Aug;20(8):1092–1094. doi: 10.1161/01.str.20.8.1092. [DOI] [PubMed] [Google Scholar]
  33. Prime suspect for cystic kidneys. Nat Genet. 1994 Jul;7(3):341–342. doi: 10.1038/ng0794-341. [DOI] [PubMed] [Google Scholar]
  34. Raskin N. H., Fishman R. A. Neurologic disorders in renal failure (second of two parts). N Engl J Med. 1976 Jan 22;294(4):204–210. doi: 10.1056/NEJM197601222940406. [DOI] [PubMed] [Google Scholar]
  35. Ravine D., Walker R. G., Gibson R. N., Forrest S. M., Richards R. I., Friend K., Sheffield L. J., Kincaid-Smith P., Danks D. M. Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet. 1992 Nov 28;340(8831):1330–1333. doi: 10.1016/0140-6736(92)92503-8. [DOI] [PubMed] [Google Scholar]
  36. Ruggieri P. M., Poulos N., Masaryk T. J., Ross J. S., Obuchowski N. A., Awad I. A., Braun W. E., Nally J., Lewin J. S., Modic M. T. Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology. 1994 Apr;191(1):33–39. doi: 10.1148/radiology.191.1.8134594. [DOI] [PubMed] [Google Scholar]
  37. Ryu S. J. Intracranial hemorrhage in patients with polycystic kidney disease. Stroke. 1990 Feb;21(2):291–294. doi: 10.1161/01.str.21.2.291. [DOI] [PubMed] [Google Scholar]
  38. San Millán J. L., Viribay M., Peral B., Martínez I., Weissenbach J., Moreno F. Refining the localization of the PKD2 locus on chromosome 4q by linkage analysis in Spanish families with autosomal dominant polycystic kidney disease type 2. Am J Hum Genet. 1995 Jan;56(1):248–253. [PMC free article] [PubMed] [Google Scholar]
  39. Scelsi R., Verri A. P., Bono G., Marbini A. Familial amyloid polyneuropathy: report of an autopsy case with neuropathy, vitreous opacities and polycystic kidney. Eur Neurol. 1989;29(1):27–32. doi: 10.1159/000116372. [DOI] [PubMed] [Google Scholar]
  40. Schwartz R. B. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 Jun 27;334(26):1743–1746. doi: 10.1056/NEJM199606273342613. [DOI] [PubMed] [Google Scholar]
  41. Wiebers D. O., Torres V. E. Screening for unruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med. 1992 Sep 24;327(13):953–955. doi: 10.1056/NEJM199209243271310. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES